Solid Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
Key Highlights
- ➤Solid Biosciences will participate in the 2026 Jefferies Global Healthcare Conference
- ➤Bo Cumbo will join a November 16 fireside chat at 2:30 p.m. GMT
- ➤Management will hold investor one-on-one meetings during the conference
- ➤Solid’s pipeline includes SGT-003, SGT-212, SGT-501, and SGT-601
Expert Statements
Bo Cumbo, President and CEO of Solid Biosciences
“will participate in a fireside chat on Monday, November 16, 2026, at 2:30 p.m. GMT (9:30 a.m. ET)”
CHARLESTOWN, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conference: * 2026 Jefferies Global Healthcare Conference in London Bo Cumbo, President and CEO, will participate in a fireside chat on Monday, November 16, 2026, at 2:30 p.m. GMT (9:30 a.m. ET). A live webcast of the presentation will be available by clicking here. Members of management will participate in investor one-on-one meetings.
The webcast replay will be archived for 90 days on the Events page.
Get started
Create a free account to read the full story.